Scleroderma--developing measures of response.
Where this comes from
- Record sourced from PubMed, PMID 16331791.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The scleroderma research community continued its focus on the development and proper validation of the outcome measures for clinical trials in scleroderma during the special interest group meeting at OMERACT 7. Deliberations focused on progress in the assessment of gastrointestinal disease, renal physiology, vascular damage, and the unique challenges inherent in studying pediatric patients with scleroderma.
Medical subject headings
- Outcome Assessment, Health Care
- Scleroderma, Localized
- Scleroderma, Systemic